𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of high dose chemotherapy with amifostine and concurrent irradiation in limited disease small cell lung cancer (SCLC)

✍ Scribed by Falchero, L; Fournel, P; Court-Fortune, I; Hominal, S; Rebattu, P; Souquet, P.J; Perol, M; Janicot, H; Riou, R; Tchenio, X; Marichy, C


Book ID
118569799
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
107 KB
Volume
29
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II trial of irinotecan and cisplat
✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,